首页 | 本学科首页   官方微博 | 高级检索  
检索        

轻型再生障碍性贫血43例疗效分析
引用本文:王书春,邹尧,张丽,刘芳,陈晓娟,杨文钰,阮敏,刘天峰,王雅琴,周剑锋,曾慧敏,郭晔,陈玉梅,竺晓凡.轻型再生障碍性贫血43例疗效分析[J].中国小儿血液与肿瘤杂志,2011,16(4).
作者姓名:王书春  邹尧  张丽  刘芳  陈晓娟  杨文钰  阮敏  刘天峰  王雅琴  周剑锋  曾慧敏  郭晔  陈玉梅  竺晓凡
作者单位:中国医学科学院血液学研究所血液病医院儿科,天津,300020
基金项目:卫生部部属(管)医院2010-2012年度临床学科重点项目
摘    要:目的分析轻型再生障碍性贫血(MAA)患儿的转归。方法回顾性分析1996年1月-2009年1月在我院治疗的43例MAA患儿的临床资料。所有患儿诊断后均按照患儿家长意愿选择以下三种治疗方案中的一种:中药组(Ⅰ组,3例):只接受中药治疗;雄激素+中药组(Ⅱ组,10例):接受中药联合康力龙0.1 mg/(kg.d)]治疗;环孢菌素A+雄激素+中药(Ⅲ组,30例):接受环孢菌素A、康力龙0.1 mg/(kg.d)]及中药治疗。中位随访时间为42个月(5~116个月)。结果在随访时间内,Ⅰ组3例患儿中仅有1例获得部分缓解,1例在随访73个月时进展为重型再生障碍性贫血(SAA),1例无效;Ⅱ组10例患儿中有3例(30%)获得部分缓解,其余7例(70%)均无效,无一例进展为SAA;Ⅲ组30例患儿中有9例(30%)获得完全缓解,5例(17%)获得部分缓解,1例(3%)在随访至11个月时进展为SAA,其余15例(50%)无效。结论早期给予干预的MAA患儿进展为SAA比率较低。

关 键 词:贫血  再生障碍性  免疫抑制治疗  雄激素  环孢菌素

Therapeutic analysis of children with mild aplastic anemia
WANG Shuchun,ZOU Yao,ZHANG Li,LIU Fang,CHEN Xiaojuan,YANG Wenyu,RUAN Min,LIU Tianfeng,WANG Yaqin,ZHOU Jianfeng,ZENG Huimin,GUO Ye,CHEN Yumei,ZHU Xiaofan.Therapeutic analysis of children with mild aplastic anemia[J].Journal of China Pediatric Blood and Cancer,2011,16(4).
Authors:WANG Shuchun  ZOU Yao  ZHANG Li  LIU Fang  CHEN Xiaojuan  YANG Wenyu  RUAN Min  LIU Tianfeng  WANG Yaqin  ZHOU Jianfeng  ZENG Huimin  GUO Ye  CHEN Yumei  ZHU Xiaofan
Institution:WANG Shuchun,ZOU Yao,ZHANG Li,LIU Fang,CHEN Xiaojuan,YANG Wenyu,RUAN Min,LIU Tianfeng,WANG Yaqin,ZHOU Jianfeng,ZENG Huimin,GUO Ye,CHEN Yumei,ZHU Xiaofan.Deparmtent of Pediatric,Institute of Hematology and Blood Diseases Hospital,CAMS and PUMC,Tianjin 300020,China
Abstract:Objective To investigate the incidence and progression of mild aplastic anemia(MAA).Methods Forty-three children with MAA treated in our hospital from January of 1996 to January of 2009 were reviewed retrospectively.Three patients(groupⅠ) were selected to receive Chinese herbal drugs only.Ten patients(groupⅡ) were selected to receive Chinese herbal drugs and stanozolol,while the rest(groupⅢ) were selected to receive Chinese herbal drugs combined with stanozolol and cyclosporin-A.Results At a median follow-up of 42 months(range from 5 to 116 months),one patient in group I developed to SAA and one had a partial remission;three patients in group Ⅱ(30%) had a partial remission and the rest(70%) had no effect;nine patients in group Ⅲ(30%) got a complete remission,five patients(17%) had a partial remission,one(3%) developed to SAA,and the rest(50%) had no effect.Conclusions Patients with MAA given early intervention had lower ratio to develop SAA.
Keywords:Anemia  Aplastic  Immunosuppressive therapy  Androgen  Cyclosporine  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号